Periprosthetic Joint Infection Bubble Study
Recruiting now · Phase 2
Conditions studied: Periprosthetic Joint Infection (PJI)
In brief
Patients with an infected knee replacement will receive their standard of care surgical treatment of the infection, with and without additional ultrasound microbubble treatment (randomly divided 50/50 in the active and control groups). Subjects in the active group will receive a local bolus injection of antibiotics and ultrasound-active microbubbles within 24 hours of their revision surgery. The fundamental hypothesis is that a decrease in re-infection rates of at least 24% can be achieved in the active group relative to controls.
Key facts
- Study ID
- NCT07599865
- Run by
- Thomas Jefferson University
- People needed
- 100
- Starts
- 2026-06-30
- Expected to finish
- 2030-06-01
- Last updated by the study team
- 2026-07-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Be at least 18 years of age
- Be medically stable
- If female of child-bearing potential, must have a negative pregnancy test
- Be conscious and able to comply with study procedures
- Have read and signed the IRB-approved Informed Consent form for participating in the study
- For Cohort 1, be scheduled for one- or two-stage exchange arthroplasty revision surgery for PJI of the knee
- For Cohort 2, be scheduled for DAIR revision surgery for PJI of the knee
You may not qualify if…
- Females who are pregnant or nursing
- Patients currently on chemotherapy requiring systemic infusion treatment
- Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable
- Patients with a history of anaphylactic allergy to perflutren or any other components of Definity
- Patients with a history of failed one- or two-stage revision for infection
- Patients for which placement of a surgical drain is contraindicated
- Patients in protected classes (e.g., prisoners)
Where it is running
- Thomas Jefferson University/Rothman Institute — Philadelphia, Pennsylvania, United States (enrolling)
- University of Pittsburgh Medical Center (UPMC) — Pittsburgh, Pennsylvania, United States
- UT Southwestern Medical Center — Dallas, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.